SQSTM1 and breast carcinoma: Notably, however, nonsteroidal AIs (Letrozole and Anastrozole) did not increase LC3-I/II or suppress SQSTM1/p62 levels in cells, indicating that these treatments may not induce autophagy in breast cancer cells (73).